IGIclal Gurses

Iclal Gurses

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iclal Gurses has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical and Histopathological Significance of Immunohistochemical β‐Human Chorionic Gonadotropin (β‐ hCG ) Expression in Mononuclear Seminoma Cells

    by Göktuğ Kalender, Muhammet Demirbilek, Kadir Can Şahin, Emre Akkuş, Hamdi Özkara, Zeyneb Ali Yılmaz, Bülent Önal, İcLal Gürses

    Objectives: To examine the morphological features of cases with immunohistochemical (IHC) expression of beta‐human chorionic gonadotropin (β‐hCG) in mononuclear seminoma cells (MSC) and to investigate the histopathological and clinical significance of this expression pattern. Methods: A total of 76 patients with pure seminoma (without syncytiotrophoblastic giant cells) and at least 1 year of follow‐up were included in the study. IHC staining for β‐hCG and CD117 (c‐KIT) was retrospectively performed. The β‐hCG and CD117 expression patterns in MSC were scored as negative (0%), focal (0%–5%), patchy (6%–50%), diffusely positive (> 50%). The patients were grouped into clinical stage (CS) I and CS II–III, and their clinical and histopathological parameters were compared. Results: The median age of the 76 patients was 34 years (range, 28–42), and the median follow‐up duration was 59 months (range, 39–79). 61 patients (80.3%) were classified as CS I and 15 patients (19.7%) as CS II–III. In multivariable analysis, the presence of IHC β‐hCG expression was associated with CS (OR = 2.238, 95% CI: 1.092–4.751, p = 0.028). In CS I cases, a patchy/diffuse expression pattern was significantly correlated with rete testis invasion (RTI) ( p = 0.001). An inverse relationship was observed between β‐hCG expression and CD117 expression in tumor cells ( p = 0.002). Conclusions: β‐hCG expression in MSC is associated with CS and, in CS I patients, the expression pattern is associated with RTI. As MSC may exhibit anaplastic/atypical morphological features, comprehensive tumor sampling and β‐hCG immunohistochemical staining may be valuable.

  • Open Access

    A Novel Homozygous CFH Variant Associated with Atypical Hemolytic Uremic Syndrome Triggered by Colorectal Cancer: A Case Report

    by Mert Berke Gür, Şeyda Gül Özcan, Mevlut Tamer Dinçer, Ahmet Murt, İcLal Gürses, Sinan Trabulus, Nurhan Seyahi

    Complement-mediated thrombotic microangiopathy (cmTMA), historically referred to as atypical hemolytic uremic syndrome, is driven by dysregulated alternative complement activation and is often unmasked by secondary triggers. A 40-year-old man with pre-existing hypertension (peak blood pressure: 145/94 mmHg) who presented with microangiopathic hemolytic anemia, severe thrombocytopenia, and acute kidney injury requiring hemodialysis is reported. Therapeutic plasma exchange was initiated while thrombotic thrombocytopenic purpura was being excluded, and eculizumab was started after meningococcal vaccination and antibiotic prophylaxis (900 mg weekly induction followed by biweekly maintenance). During the workup for recurrent hematochezia, a transverse colon adenocarcinoma was diagnosed and resected, without the need for adjuvant chemotherapy. Hematologic remission was achieved on eculizumab, and renal function partially recovered, allowing discontinuation of dialysis at 3 months. However, chronic kidney disease (CKD) persisted at the last follow-up (creatinine 2.17 mg/dL; estimated glomerular filtration rate(eGFR) 38 mL/min/1.73 m2; CKD stage 3b). Genetic analysis identified a homozygous CFH splice-site variant (c.1159+4A>C), supporting underlying complement dysregulation. This case highlights the importance of prioritizing genetic evaluation and modern nomenclature in cmTMA occurring in the context of malignancy. Cite this article as: Gür MB, Özcan SG, Dinçer MT, et al. A novel homozygous CFH variant associated with atypical hemolytic uremic syndrome triggered by colorectal cancer: A case report. Cerrahpaşa Med J. 2026, 50, 0103, doi: 10.5152/cjm.2026.25103.

  • Open Access

    A different presentation of tubulointerstitial nephritis and uveitis syndrome mimicking Sjögren’s syndrome

    by Reyhan Yılmaz, Ahmet Murt, Iclal Gurses, Serdal Ugurlu

    Tubulointerstitial nephritis (TIN) and uveitis (TINU) syndrome is an uncommon disease mainly identified by two entities specified in its name: TIN and uveitis.[1,2] According to Mandeville et al.’s[2] diagnostic criteria, definitive diagnosis should be established with renal biopsy and ophthalmologic examination after possible differential diagnoses are excluded. A 55-year-old female patient was referred to our rheumatology clinic for evaluation of dry eyes and malaise. In the first evaluation, the patient reported dry eyes and mouth and had a history of idiopathic unilateral anterior uveitis. After seeing an increased creatinine level (2.64 mg/dL), we consulted the case with the nephrology unit. As a part of nephrology examination, 24-h urine collection revealed 848 mg proteinuria per day. In addition, 1+ erythrocyte was detected in a spot urine test with seven leukocytes and five erythrocytes per high-power field of the urine sediment. Urine culture was sterile. Normal anion gap acidosis was detected in blood gas analysis (pH: 7.22, bicarbonate: 16.6, and anion gap: 7). C-reactive protein (CRP) level was 109.7 mg/L. Other laboratory results are shown in Table 1. Ophthalmologic examination revealed anterior uveitis. The Schirmer test (3 mm in the right eye and 0 mm in the left eye) and tear break-up time test (5 sec in the right eye and 3 sec in the left eye) confirmed dryness in both eyes. Antinuclear antibody screen by indirect immunofluorescence technique showed a homogenous nuclear pattern with 1:160 titer. Rheumatologic findings, proteinuria, and increasing creatinine levels necessitated a renal biopsy, which revealed TIN with prominent eosinophilic infiltration in both cortical and medullary interstitium (Figure 1). Furthermore, a salivary gland biopsy was performed, which did not show any specific findings. Anti-SSA and anti-SSB were negative in the extractable nuclear antigen panel. After ruling out differential diagnoses, TINU syndrome was diagnosed. We commenced prednisolone with a dose of 0.5 mg/kg/day. Erythrocyte sedimentation rate normalized after two weeks of treatment, and the creatinine levels dropped. Uveitis went into remission. The steroid dose was tapered, and the patient completed the therapy in a total of eight weeks. As a maintenance therapy, mycophenolic acid 500 mg twice daily was prescribed. Subsequently, ongoing improvement in creatinine and CRP levels were observed. The patient is still under follow-up, and the most recent laboratory results showed creatinine and CRP levels of 1.23 mg/dL and 2.71 mg/L, respectively. This case demonstrated an uncommon clinical presentation compared to other reported TINU cases due to sicca symptoms. In the literature, dryness has been described as a rare symptom and is only seen in 3% of patients.[2] To the best of our knowledge, there is only one reported case in which a patient presented with sicca symptoms and was diagnosed with TINU syndrome.[3] In the diagnostic approach to TINU syndrome, exclusion of diseases such as sarcoidosis and Sjögren’s disease is necessary since oculorenal involvement might be seen in the course of these diseases.[4] Although Sjögren’s disease might be suspected in this 55-year-old female patient with sicca symptoms,[5] salivary gland biopsy findings and the extractable nuclear antigen panel were not compatible with Sjögren’s disease. Additionally, as there was no granuloma formation in the kidney biopsy, TIN could not be attributed to sarcoidosis or Sjögren's disease. Furthermore, there was no hypercalcemia or hypercalciuria that would suggest sarcoidosis. Moreover, fluorodeoxyglucose-positron emission tomography also did not show any specific findings and ruled out sarcoidosis. Besides, the patient didn’t have any respiratory symptoms. Negative direct immunofluorescence and normal serum complement levels helped rule out lupus nephritis and immunoglobulin G4-related TIN. Antiphospholipid anti-double stranded DNA and anti-Smith antibodies were also negative, and the patient did not have any neuropsychiatric, mucocutaneous, serosal, or musculoskeletal symptoms. Therefore, the patient did not fulfill the 2019 EULAR (European Alliance of Associations for Rheumatology)/ACR (American College of Rheumatology) systemic lupus erythematosus classification criteria. Drug-related interstitial nephritis was also unlikely as there were no drugs that were commenced or stopped during the diagnosis and follow-up period. In conclusion, this reported TINU case with an overlap of symptoms with Sjögren’s disease underlines that TINU might have different clinical features. This report points out a new perspective on approaches in uncommon clinical presentations of patients with oculorenal involvement.

  • Open Access

    Over Karsinomlarında Östrojen, Progesteron Reseptörleri, C-Erb B-2, P53 ve BRCA1’in İmmünhistokimyasal Ekspresyonu ve Prognostik Önemleri

    by Didar Gürsoy Gürsoy, İclal Gürses, Vedia Bennu Gi̇lan, Bahar Taşdelen, Ali Arican, Celalettin Tok

    Our study aimed to determine immunohistochemical expression of ER, PR, C-erbB-2, p53 and BRCA1 genes and their relationship with clinicopathological features and prognostic significance. The present study included 85 patients that were diagnosed with epithelial OC, treated and followed-up between 2002 and 2012 at Mersin University, Faculty of Medicine. Immunohistochemical expression of ER, PR, C-erbB-2, p53 and BRCA1 and their relation-ship with clinicopathological parameters were evaluated. In serous carcinomas, expression of ER was significantly associated with metastasis to the fallopian tube, expression of PR was significantly associated with patient’s age, expression of p53 was significantly associated with the progression-free survival (PFS), cytoplasmic expression of BRCA1 was significantly associated with the overall survival (OS) and PFS. In pathogenesis groups, 55 tumors were type 1, and 30 tumors were type 2. There were significant correlations with ER, PR and p53 expressions between the two groups. In our study, PR and p53 were prognostic factors in serous carcinoma. Extensive studies that contain more cases in each histological group are needed to determine the prognostic value of these five immunohistochemical markers.

  • Second Primary Malignant Tumours in Patients with Renal Cell Carcinoma

    by Hale Demir, Özden Yülek, Ertuğrul Oruç, Buğra Taygun Gülle, Deniz Nur Demir, Çetin Demirdağ, Haydar Durak, İclal Gürses, Nesrin Uygun


  • Open Access

    Retrospective Evaluation of 14 Patients with Bone and Joint Tuberculosis in Mersin, Turkey

    by Gönül Aslan, Nurbanu Kurnaz, Mahmut Ülger, İrFan Ayan, Sermin Tok Umay, İcLal Gürses

  • Open Access

    Alport Sendromu tanısında böbrek biyopsisi ve elektron mikroskobinin önemi

    by Serra Sürmeli Döven, Selçuk Teke, İcLal Gürses, Banu Coşkun Yılmaz, Ebru Ballı, Ali Delibaş

    Amaç: Alport sendromu hematüri, ilerleyici böbrek yetmezliği, işitme kaybı ve oküler anormalliklerle seyreden bir hastalıktır. Bu çalışmada merkezimizde Alport sendromu tanısıyla izlenen hastaların demografik, klinik ve laboratuvar bulguları ile renal biyopsilerinin histopatolojik ve elektron mikroskobik bulgularının değerlendirilmesi amaçlanmıştır. Yöntem: Çocuk Nefroloji Kliniğinde Haziran 2004 ile Ocak 2018 tarihleri arasında takip edilen 14 Alport sendromlu hastanın başvuru şikayetleri, aile hikayesi, renal tutulumu, göz ve işitme bulguları, böbrek biyopsilerinin histopatolojik ve elektron mikroskobik değerlendirmeleri geriye dönük olarak incelendi. Bulgular: Yedisi kız ve yedisi erkek olmak üzere toplam 14 hasta değerlendirildi. Hastaların yaşları 15 ay-17 yıl arasındaydı (ortalama 10.7±3.8 yıl). On bir hasta hematüri, bir hasta vücutta şişlik, iki hasta ise şikâyeti olmaksızın ailelerinde Alport sendromu öyküsü olması nedeniyle araştırılmak üzere başvurdu. Anne-baba arasında akrabalık beş hastada bulunurken, 11 hastanın ailesinde Alport sendromu öyküsü mevcuttu. Sensorinöral işitme kaybı yedi hastada saptandı. Bilateral anterior lentikonus son dönem böbrek yetmezliği kliniğinde başvuran bir hastada saptandı. Böbrek biyopsisi yapılan 10 hastanın elektron mikroskobik incelenmesinde, tüm vakalarda glomerül bazal membranında incelmeler, kalınlaşmalar ve sepet görünümü ile karakterize düzensizlikler gösterildi. Sonuç: Hematüri şikayetiyle başvuran hastalarda aile öyküsünün sorgulanması, göz muayenesi ve işitme testlerinin yapılması Alport sendromu tanısını koymada yol gösterici olmaktadır. Elektron mikroskobide glomerul bazal membrandaki tipik değişikliklerin görülmesi tanıyı kesinleştirmektedir.


  • Open Access

    What does the data of 354,725 patients from turkey tell US about cervical smear epithelial cell abnormalities? - the epithelial cell abnormality rate is increasing - quality control studies and corrective activity are musts

    by Ilknur Cetinaslan Turkmen, Alp Usubutun, Asli Cakir, Ozlem Aydin, Filiz Aka Bolat, Metin Akbulut, Serdar Altinay, Sema Arici, Figen Aslan, Muzeyyen Astarci, et al.

    There is no other screening program close to the success rate of PAP test. Cervical cytology constitutes a large workload so that quality control in cervical cytology is important for the quality assurance of pathology laboratories. In this study, we collected the cervical cytology results from all over Turkey and discussed the parameters influencing the quality of the PAP test. The study was conducted with Turkish gynaecopathology working group and 38 centers (totally 45 hospitals) agreed to contribute from 24 different cities. The study was designed to cover the cervical cytology results during 2013. The results were evaluated from the data based on an online questionnaire. The total number of Epithelial Cell Abnormality was 18,020 and the global Epithelial Cell Abnormality rate was 5.08% in the total 354,725 smears and ranging between 0.3% to 16.64% among centers. The Atypical squamous cells /Squamous intraepithelial lesion ratios changed within the range of 0.21-13.94 with an average of 2.61. When the centers were asked whether they performed quality assurance studies, only 14 out of 28 centers, which shared the information, had such a control study and some quality parameters were better in these centers. There is an increase in the global Epithelial Cell Abnormality rate and there are great differences among centers. Quality control studies including the Atypical squamous cells/Squamous intraepithelial lesion ratio are important. Corrective and preventive action according to quality control parameters is a must. A cervical cytology subspecialist in every center can be utopic but a dedicated pathologist in the center is certainly needed.